Get started
Author

Otakar Čapoun

Observed names: MUDr.Otakar Čapoun, O Capoun, O. CAPOUN, O. Capoun, O. Čapoun, O.Č. Čapoun, OTAKAR CAPOUN, OTAKAR ČAPOUN, Otakar Capoun, Čapoun, Otakar
Observed institutions: University of Graz, Medical University of Graz, Charles University, European Association of Urology, Vienna General Hospital, General University Hospital in Prague, Medical University of Vienna
ORCID: 0000-0002-2332-3174
Observed ORCID: 0000-0002-2332-3174
OpenAlex ID: A5019083341
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 · Marko Babjuk, Andreas Böhle, et al. · European Urology · 2,258
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
2021 · Marko Babjuk, Maximilian Burger, et al. · European Urology · 1,703
PDF
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 · Morgan Rouprêt, Marko Babjuk, et al. · European Urology · 1,364
PDF
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
2019 · Marko Babjuk, Maximilian Burger, et al. · European Urology · 1,307
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
2023 · Morgan Rouprêt, Thomas Seisen, et al. · European Urology · 551
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
2021 · Richard J. Sylvester, Oscar Rodríguez, et al. · European Urology · 493
PDF
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 · Paolo Gontero, Alison Birtle, et al. · European Urology · 357
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
2017 · Viktor Soukup, Otakar Čapoun, et al. · European Urology · 286
PDF
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update
2025 · Alexandra Masson-Lecomte, Alison Birtle, et al. · European Urology · 161
Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel
2018 · Viktor Soukup, Otakar Čapoun, et al. · European Urology Focus · 108
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study
2021 · Bas W.G. van Rhijn, Anouk E. Hentschel, et al. · European Urology Oncology · 107
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria
2022 · Bhavan P. Rai, José Luis Dominguez Escrig, et al. · European Urology · 81
PDF
MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection
2016 · S. POSPISILOVA, E. PAZOURKOVA, et al. · Neoplasma · 70
PDF
Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer
2015 · Antonin Brisuda, Eva Pazourkova, et al. · Urologia Internationalis · 45
Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma
2015 · Viktor Soukup, Marta Kalousová, et al. · Urologia Internationalis · 44
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
2019 · Anouk E. Hentschel, Bas W.G. van Rhijn, et al. · Urologic Oncology Seminars and Original Investigations · 43
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
2022 · Sinan Khadhouri, Kevin M. Gallagher, et al. · European Urology Focus · 32
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non–muscle-invasive Spectrum
2023 · Irene J. Beijert, Anouk E. Hentschel, et al. · European Urology Oncology · 31
The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study
2014 · V. Soukup, J. Dušková, et al. · Urologia Internationalis · 30
Prevention of bladder cancer incidence and recurrence
2017 · Francesco Soria, Giancarlo Marra, et al. · Current Opinion in Urology · 27
Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression
2017 · Marketa Skerenova, Veronika Mikulova, et al. · Biomedical Papers · 26
PDF
Deep-learning-based reconstruction of T2-weighted magnetic resonance imaging of the prostate accelerated by compressed sensing provides improved image quality at half the acquisition time
2024 · Martin Jurka, Iva Macova, et al. · Quantitative Imaging in Medicine and Surgery · 23
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
2023 · Steven MacLennan, Nuno Azevedo, et al. · European Urology · 22
EAU Guidelines on Nonmuscle-invasive Bladder Cancer (TaT1 and CIS) – A Summary of the 2026 Guidelines Update
2026 · Paolo Gontero, Paramananthan Mariappan, et al. · European Urology · 21
The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy
2020 · Jiří Stejskal, Vanda Adamcová, et al. · World Journal of Urology · 20
Works count: 163
Citation count: 9,580
H-index: 23
I10-index: 36
Year
Topic
Type